Key result
The MedTech Dispo maglev centrifugal blood pump demonstrated stable performance in calves over 2 weeks, with no thrombus formation and plasma free hemoglobin maintained below 4 mg/dL.
Population
In vitro model and in vivo model consisting of seven calves
Design
Preclinical
Follow-up
2 weeks
Authors
Loading...
Should not yet change clinical practice; leaves open human translation of maglev pump performance.
The MedTech Dispo maglev centrifugal blood pump demonstrated stable performance and biocompatibility in a 2-week in vivo calf model, suggesting potential for short-term circulatory support.
Someya et al. (2009) studied Extracorporeal circulatory support (n=7). MedTech Dispo (disposable maglev centrifugal blood pump) was evaluated on Pump performance, thrombus formation, and plasma free hemoglobin. The MedTech Dispo maglev centrifugal blood pump demonstrated stable performance in calves over 2 weeks, with no thrombus formation and plasma free hemoglobin maintained below 4 mg/dL.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: